Strs Ohio grew its position in shares of Omega Healthcare Investors Inc (NYSE:OHI) by 0.9% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 276,776 shares of the real estate investment trust’s stock after purchasing an additional 2,460 shares during the quarter. Strs Ohio owned approximately 0.13% of Omega Healthcare Investors worth $10,171,000 as of its most recent SEC filing.
Several other large investors have also recently bought and sold shares of OHI. Nordea Investment Management AB boosted its holdings in Omega Healthcare Investors by 12.6% in the 4th quarter. Nordea Investment Management AB now owns 52,807 shares of the real estate investment trust’s stock valued at $1,857,000 after purchasing an additional 5,907 shares during the period. Norges Bank bought a new position in Omega Healthcare Investors in the 4th quarter valued at $46,751,000. Geode Capital Management LLC boosted its holdings in Omega Healthcare Investors by 8.0% in the 4th quarter. Geode Capital Management LLC now owns 2,312,184 shares of the real estate investment trust’s stock valued at $81,791,000 after purchasing an additional 171,333 shares during the period. Washington Trust Bank boosted its holdings in Omega Healthcare Investors by 684.9% in the 1st quarter. Washington Trust Bank now owns 1,146 shares of the real estate investment trust’s stock valued at $44,000 after purchasing an additional 1,000 shares during the period. Finally, State of Alaska Department of Revenue boosted its holdings in Omega Healthcare Investors by 0.8% in the 1st quarter. State of Alaska Department of Revenue now owns 87,012 shares of the real estate investment trust’s stock valued at $3,318,000 after purchasing an additional 717 shares during the period. 69.27% of the stock is owned by hedge funds and other institutional investors.
In other news, CEO C Taylor Pickett sold 30,000 shares of Omega Healthcare Investors stock in a transaction on Thursday, June 20th. The shares were sold at an average price of $38.00, for a total transaction of $1,140,000.00. Following the completion of the sale, the chief executive officer now directly owns 299,133 shares of the company’s stock, valued at approximately $11,367,054. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Robert O. Stephenson sold 10,000 shares of Omega Healthcare Investors stock in a transaction on Thursday, June 20th. The stock was sold at an average price of $38.00, for a total transaction of $380,000.00. Following the sale, the chief financial officer now directly owns 223,326 shares of the company’s stock, valued at $8,486,388. The disclosure for this sale can be found here. Insiders have sold a total of 85,500 shares of company stock valued at $3,239,000 over the last ninety days. 1.16% of the stock is currently owned by insiders.
Omega Healthcare Investors (NYSE:OHI) last posted its quarterly earnings data on Tuesday, August 6th. The real estate investment trust reported $0.34 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.73 by ($0.39). Omega Healthcare Investors had a return on equity of 6.91% and a net margin of 29.38%. The company had revenue of $191.81 million for the quarter, compared to the consensus estimate of $190.46 million. During the same period in the prior year, the firm posted $0.75 earnings per share. The business’s revenue was down .5% on a year-over-year basis. Research analysts predict that Omega Healthcare Investors Inc will post 2.99 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, August 15th. Stockholders of record on Wednesday, July 31st will be issued a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 6.88%. The ex-dividend date is Tuesday, July 30th. Omega Healthcare Investors’s dividend payout ratio is currently 86.84%.
Several research analysts have commented on the stock. Zacks Investment Research raised shares of Omega Healthcare Investors from a “hold” rating to a “buy” rating and set a $42.00 price target for the company in a report on Wednesday, July 31st. Raymond James raised shares of Omega Healthcare Investors from an “outperform” rating to a “strong-buy” rating and raised their price target for the company from $40.00 to $42.00 in a report on Thursday. Five analysts have rated the stock with a hold rating, two have given a buy rating and one has issued a strong buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $38.77.
About Omega Healthcare Investors
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
Further Reading: Ex-Dividend
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.